IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

BVF Inc

Q4 2015 Holdings

Filed 2016-02-16 | 30 holdings | $43.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Cytokinetics Inc(CYTK)COM NEW23282W605$30.6M2,920,62869.7%
Cytomx Therapeutics Inc(CTMX)COM23284F105$12.7M608,84829.0%
Blueprint Medicines Corp(2L9)COM09627Y109$60.0K2,278,4590.1%
Chemocentryx Inc(CCXIEUR)COM16383L106$54.1K6,677,7220.1%
CTI Biopharma CorpCOM12648L106$53.9K43,795,6130.1%
Concert Pharmaceuticals Inc(CNCEEUR)COM206022105$42.3K2,232,0140.1%
Oncothyreon IncCOM682324108$41.7K18,799,3680.1%
Vitae Pharmaceuticals IncCOM92847N103$37.3K2,061,3250.1%
Ironwood Pharmaceuticals Inc(IRWD)COM CL A46333X108$34.0K2,935,9750.1%
Array Biopharma Inc(ARRYEUR)COM04269X105$28.2K6,682,7110.1%
Forward Pharma A/SSPONSORED ADR34986J105$27.4K1,441,2870.1%
Oncomed Pharmaceuticals IncCOM68234X102$22.3K991,4330.1%
Exelixis IncNOTE 4.250% 8/130161QAC8$22.2K$18,842,7780.1%
Loxo Oncology IncCOM548862101$20.2K711,0670.0%
Arqule Inc(ARQLUSD)COM04269E107$14.8K6,809,8430.0%
QLT IncCOM746927102$14.3K5,364,3850.0%
Tobira Therapeutics IncCOM88883P101$12.6K1,253,4010.0%
Five Prime Therapeutics Inc(FPRX)COM33830X104$12.5K300,0000.0%
Nivalis Therapeutics IncCOM65481J109$9.2K1,195,0130.0%
Xenon Pharmaceuticals Inc(XENE)COM98420N105$9.1K1,125,5720.0%
GTX Inc delCOM40052B108$7.8K11,163,1360.0%
Sunesis Pharmaceuticals IncCOM NEW867328601$4.3K4,777,3810.0%
Pain Therapeutics IncCOM69562K100$3.2K1,852,3530.0%
Catalyst Biosciences IncCOM14888D109$3.0K970,9480.0%
Globeimmune Inc(GBIM)COM37957B100$2.5K657,6530.0%
Array Biopharma IncNOTE 3.000% 6/004269XAA3$2.3K$2,500,0000.0%
Mast Therapeutics IncCOM576314108$1.6K3,696,9610.0%
Calithera Biosciences Inc(CALAEUR)COM13089P101$1.3K167,9000.0%
Biota Pharmaceutials IncCOM090694100$681350,7760.0%
Nephrogenex IncCOM640667101$627392,1560.0%